| Issue |
Title |
File |
| Vol 13, No 1 (2013) |
New Insight into P-Glycoprotein as a Drug Target |
(Eng)
|
|
Breier A., Gibalova L., Seres M., Barancik M., Sulova Z.
|
| Vol 13, No 10 (2013) |
Editorial (Thematic Issue: Green Anti-Cancer Agents and Ayur-Biotechnology: A smart approach towards improving R&D productivity.) |
(Eng)
|
|
Raja K.
|
| Vol 13, No 1 (2013) |
Sunlight Vitamin D and Skin Cancer |
(Eng)
|
|
S. Mason R., Reichrath J.
|
| Vol 13, No 1 (2013) |
Vitamin D, Sunlight and Cancer Connection |
(Eng)
|
|
F. Holick M.
|
| Vol 13, No 1 (2013) |
Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers |
(Eng)
|
|
J. Helzlsouer K., Gallicchio L.
|
| Vol 13, No 1 (2013) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 13, No 1 (2013) |
Editorial (Hot Topic: Vitamin D and Cancer: Current Evidence and Future Perspective) |
(Eng)
|
|
Pilz S.
|
| Vol 13, No 1 (2013) |
Safety Issues of Vitamin D Supplementation |
(Eng)
|
|
Zittermann A., Prokop S., F. Gummert J., Borgermann J.
|
| Vol 13, No 1 (2013) |
Epidemiology of Vitamin D and Colorectal Cancer |
(Eng)
|
|
Giovannucci E.
|
| Vol 13, No 1 (2013) |
Role of Calcium, Vitamin D, and the Extrarenal Vitamin D Hydroxylases in Carcinogenesis |
(Eng)
|
|
Hobaus J., Thiem U., M. Hummel D., Kallay E.
|
| Vol 13, No 1 (2013) |
Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012? |
(Eng)
|
|
Souberbielle J., Cavalier E.
|
| Vol 13, No 1 (2013) |
Vitamin D, Sunlight, and the Epidemiology of Prostate Cancer |
(Eng)
|
|
G. Schwartz G.
|
| Vol 13, No 1 (2013) |
Relevance of Vitamin D in Bone and Muscle Health of Cancer Patients |
(Eng)
|
|
Bischoff-Ferrari H.
|
| Vol 13, No 10 (2013) |
First Ayurvedic Approach Towards Green Drugs: Anti Cervical Cancer-Cell Properties of Clerodendrum viscosum Root Extract |
(Eng)
|
|
Sun C., Nirmalananda S., Jenkins C., Debnath S., Balambika R., Fata J., Raja K.
|
| Vol 13, No 10 (2013) |
Betulin-Betulinic Acid Natural Product Based Analogs as Anti-Cancer Agents |
(Eng)
|
|
Jonnalagadda S., Corsello M., Sleet C.
|
| Vol 13, No 10 (2013) |
Chemoprevention of Skin Cancer: Effect of Lawsonia inermis L. (Henna) Leaf Powder and its Pigment Artifact, Lawsone in the Epstein- Barr Virus Early Antigen Activation Assay and in Two-Stage Mouse Skin Carcinogenesis Models |
(Eng)
|
|
Kapadia G., Rao G., Sridhar R., Ichiishi E., Takasaki M., Suzuki N., Konoshima T., Iida A., Tokuda H.
|
| Vol 13, No 10 (2013) |
Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization |
(Eng)
|
|
Provot O., Hamze A., Peyrat J., Brion J., Alami M.
|
| Vol 13, No 10 (2013) |
In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach |
(Eng)
|
|
Gadhe C., Kothandan G., Cho S.
|
| Vol 13, No 10 (2013) |
Effects of Limonoid Cedrelone on MDA-MB-231 Breast Tumor Cells in vitro |
(Eng)
|
|
Fuzer A., Filho J., Becceneri A., Santos D., Silva M., Vieira P., Fernandes J., Selistre-de-Araujo H., Cazal C., Cominetti M.
|
| Vol 13, No 10 (2013) |
ACKNOWLEDGEMENTS TO THE REVIEWERS |
(Eng)
|
|
.
|
| Vol 13, No 2 (2013) |
Editorial (Hot Topic: Translational Medicine is Promoting Cross-talk of Interdiscipline) |
(Eng)
|
|
Yu Y.
|
| Vol 13, No 2 (2013) |
Antiangiogenic Triterpenes Isolated from Chinese Herbal Medicine Actinidia chinensis Planch |
(Eng)
|
|
Zhu W., Yu D., Zhao M., Lin M., Lu Q., Wang Q., Guan Y., Li G., Luan X., Yang Y., Qin X., Fang C., Yang G., Chen H.
|
| Vol 13, No 2 (2013) |
Cell Dormancy and Tumor Refractory |
(Eng)
|
|
Yu Y., Zhu Z.
|
| Vol 13, No 2 (2013) |
A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies |
(Eng)
|
|
Jia Z., Wang Y., Hu Y., McLaren C., Yu Y., Ye K., Xia X., A. Koziol J., Lernhardt W., McClelland M., Mercola D.
|
| Vol 13, No 2 (2013) |
Functional Nanoplatforms for Enhancement of Chemotherapeutic Index |
(Eng)
|
|
Yang J., Lee E., Ku M., Huh Y., Cheong J.
|
| Vol 13, No 10 (2013) |
Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines |
(Eng)
|
|
Mahbub A., Maitre C., Haywood-Small S., McDougall G., Cross N., Jordan-Mahy N.
|
| Vol 13, No 10 (2013) |
Synthesis and Biological Evaluation of Diaryl Ether Linked DC-81 Conjugates as Potential Antitumor Agents |
(Eng)
|
|
Ramaiah M., Murty J., Sultana F., Bharathi E., Ramakrishna G., Sarma P., Lavanya A., Pushpavalli S., Bhadra M., Kamal A., Viswanath A.
|
| Vol 13, No 10 (2013) |
Curcumin Potentiates The Ability of Sunitinib to Eliminate the VHL-lacking Renal Cancer Cells 786-O: Rapid Inhibition of Rb Phosphorylation as a Preamble to Cyclin D1 Inhibition |
(Eng)
|
|
Debata P., Begum S., Mata A., Genzer O., Kleiner M., Banerjee P., Castellanos M.
|
| Vol 13, No 10 (2013) |
Stereoselective Synthesis of Pyroglutamate Natural Product Analogs from α- Aminoacids and their Anti-Cancer Evaluation |
(Eng)
|
|
Tekkam S., Alam M., Just M., Berry S., Johnson J., Jonnalagadda S., Mereddy V.
|
| Vol 13, No 10 (2013) |
Dendrimer-Curcumin Conjugate: A Water Soluble and Effective Cytotoxic Agent Against Breast Cancer Cell Lines |
(Eng)
|
|
Debnath S., Saloum D., Dolai S., Sun C., Averick S., Raja K., Fata J.
|
| Vol 13, No 10 (2013) |
Garcinia Benzophenones Inhibit the Growth of Human Colon Cancer Cells and Synergize with Sulindac Sulfide and Turmeric |
(Eng)
|
|
Einbond L., Mighty J., Kashiwazaki R., Figueroa M., Jalees F., Acuna U., LeGendre O., Foster D., Kennelly E.
|
| Vol 13, No 10 (2013) |
Editorial: Plant Derived Secondary Metabolites as Anti-Cancer Agents |
(Eng)
|
|
Rawat D., Singh R.
|
| Vol 13, No 10 (2013) |
Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies |
(Eng)
|
|
Qazi A., Hussain A., Hamid A., Qurishi Y., Majeed R., Ahmad M., Najar R., Bhat J., Singh S., Zargar M., Ali S., Saxena A.
|
| Vol 13, No 10 (2013) |
Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines |
(Eng)
|
|
Cazal C., Choosang K., Severino V., Fernandes J., Silva M., Vieira P., Nascimento M., Almeida G., Vasconcelos M., Pakkong P., Pinto M.
|
| Vol 13, No 10 (2013) |
Myricetin Induces Apoptosis in HepG2 Cells Through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway |
(Eng)
|
|
Zhang X., Chen S., Tang L., Shen Y., Luo L., Xu C., Liu Q., Li D.
|
| Vol 13, No 10 (2013) |
Cinnamaldehyde-Induced Apoptosis in Human Hepatoma PLC/PRF/5 Cells Involves the Mitochondrial Death Pathway and is Sensitive to Inhibition by Cyclosporin A and z-VAD-fmk |
(Eng)
|
|
Lin L., Tai C., Chang S., Chen J., Wu S., Lin C.
|
| Vol 13, No 2 (2013) |
Oxaliplatin-induced Hyperexcitation of Rat Sciatic Nerve Fibers: An Intra-axonal Study |
(Eng)
|
|
Kagiava A., K. Kosmidis E., Theophilidis G.
|
| Vol 13, No 2 (2013) |
Synthesis and Biological Evaluation of Novel Antifolate Analogs as Potential Anticancer Treatment |
(Eng)
|
|
F. Stoicescu D., Rotaru M.
|
| Vol 13, No 2 (2013) |
A Natural Anticancer Agent Thaspine Targets Human Topoisomerase IB |
(Eng)
|
|
Castelli S., Katkar P., Vassallo O., Falconi M., Linder S., Desideri A.
|
| Vol 13, No 1 (2013) |
Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug? |
(Eng)
|
|
Pereira J., Levy D., L.M. Ruiz J., A. Brocardo G., A. Ferreira K., O. Costa R., G. Queiroz R., A. Maria D., E. Hallack Neto A., A.F. Chamone D., P. Bydlowski S.
|
| Vol 13, No 1 (2013) |
Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma |
(Eng)
|
|
Naderi N., Y. Madani S., Ferguson E., Mosahebi A., M. Seifalian A.
|
| Vol 12, No 3 (2012) |
Selective Histone Deacetylase Inhibitors |
(Eng)
|
|
Pan H., Cao J., Xu W.
|
| Vol 12, No 3 (2012) |
NGR-based Strategies for Targeting Delivery of Chemotherapeutics to Tumor Vasculature |
(Eng)
|
|
Zou M., Zhang L., Xie Y., Xu W.
|
| Vol 12, No 3 (2012) |
Chemotherapeutic Targeting of Cell Death Pathways |
(Eng)
|
|
Mansilla S., Llovera L., Portugal J.
|
| Vol 12, No 3 (2012) |
Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids |
(Eng)
|
|
Coderch C., Morreale A., Gago F.
|
| Vol 12, No 3 (2012) |
Melanoma and Epigenetic Treatment: Past and Future |
(Eng)
|
|
AM La Porta C.
|
| Vol 12, No 3 (2012) |
Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1 |
(Eng)
|
|
Guyard-Daumas C., Sciberras S., Fouache C., Plantier S., Studeny A., Bossard C., J. Casara P., M. Golsteyn R., M. Perron-Sierra F., Kucharkzyk N., Boucley C.
|
| Vol 12, No 3 (2012) |
The Stem Cell Niche as a Pharmaceutical Target for Prevention of Skeletal Metastases |
(Eng)
|
|
M. Chirgwin J.
|
| Vol 12, No 3 (2012) |
Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment |
(Eng)
|
|
Jiaguo H., Zhiguo L., Wenbin Z.
|
| Vol 12, No 3 (2012) |
The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences |
(Eng)
|
|
Murray V., Kandasamy N.
|
| Vol 12, No 3 (2012) |
Editorial [ Special Board Members Issue (Edior-in-Chief: Michelle Prudhomme)] |
(Eng)
|
|
Prudhomme M.
|
| Vol 12, No 2 (2012) |
Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent |
(Eng)
|
|
Vetvicka V., Fusek M.
|
| Vol 12, No 2 (2012) |
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers? |
(Eng)
|
|
Yokota T.
|
| Vol 12, No 2 (2012) |
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance |
(Eng)
|
|
S. Gayle S., L.M. Arnold S., M. O'Regan R., Nahta R.
|
| Vol 12, No 3 (2012) |
Genistein and its Synthetic Analogs as Anticancer Agents |
(Eng)
|
|
Li Q., Li C., Li Z., Zhu H.
|
| Vol 12, No 4 (2012) |
Editorial [Hot Topic: Lipids in Cancer Cell Biology and Therapy Guest Editor: Jose C. Fernandez-Checa)] |
(Eng)
|
|
Fernandez-Checa J.C.
|
| Vol 12, No 4 (2012) |
Sphingolipid Modulation: A Strategy for Cancer Therapy |
(Eng)
|
|
Delgado A., Fabrias G., Bedia C., Casas J., Abad J.L.
|
| Vol 12, No 5 (2012) |
Molecular Imaging of Cancer with Radiolabeled Peptides and PET |
(Eng)
|
|
L. Vavere A., Rossin R.
|
| Vol 12, No 5 (2012) |
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals |
(Eng)
|
|
Bolzati C., Carta D., Salvarese N., Refosco F.
|
| Vol 12, No 5 (2012) |
Peptide-Receptor Ligands and Multivalent Approach |
(Eng)
|
|
Ruzza P., Marchiani A., Antolini N., Calderan A.
|
| Vol 12, No 5 (2012) |
EDITORIAL [Hot Topic: Peptide-Receptor Ligands in Imaging and Therapy of Cancer (Guest Editor: Dr. Paolo Ruzza)] |
(Eng)
|
|
Ruzza P.
|
| Vol 12, No 4 (2012) |
Downregulation of Hypoxia-related Responses by Novel Antitumor Histone Deacetylase Inhibitors in MDAMB231 Breast Cancer Cells |
(Eng)
|
|
Naldini A., Filippi I., Cini E., Rodriquez M., Carraro F., Taddei M.
|
| Vol 12, No 4 (2012) |
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds |
(Eng)
|
|
Liu Y., Zhang C., Liu Z.
|
| Vol 12, No 4 (2012) |
Growth Inhibition of Human Non-Small Lung Cancer Cells H460 By Green Tea and Ginger Polyphenols |
(Eng)
|
|
Hessien M., El-Gendy S., Donia T., Sikkena M.A.
|
| Vol 12, No 4 (2012) |
Ganglioside GD3 as a Raft Component in Cell Death Regulation |
(Eng)
|
|
Sorice M., Garofalo T., Misasi R., Manganelli V., Vona R., Malorni W.
|
| Vol 12, No 4 (2012) |
Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism |
(Eng)
|
|
Morales A., Mari M., Garcia-Ruiz C., Colell A., Fernandez-Checa J.C.
|
| Vol 12, No 4 (2012) |
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death |
(Eng)
|
|
Mullen T.D., Obeid L.M.
|
| Vol 12, No 4 (2012) |
Cholesterol, Cardiolipin, and Mitochondria Permeabilisation |
(Eng)
|
|
Lucken-Ardjomande Hasler S.
|
| Vol 12, No 4 (2012) |
Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy |
(Eng)
|
|
Ballereau S., Levade T., Genisson Y., Andrieu-Abadie N.
|
| Vol 12, No 4 (2012) |
Statins and Protein Prenylation in Cancer Cell Biology and Therapy |
(Eng)
|
|
Garcia-Ruiz C., Morales A., Fernandez-Checa J.C.
|
| Vol 12, No 5 (2012) |
Optical and Multimodal Peptide-Based Probes for In Vivo Molecular Imaging |
(Eng)
|
|
Melendez-Alafort L., Carlo Muzzio P., Rosato A.
|
| Vol 12, No 2 (2012) |
Bisphosphonates and Breast Cancer Prevention |
(Eng)
|
|
T. Chlebowski R., Col N.
|
| Vol 12, No 10 (2012) |
Epigenetic Mechanisms Underlying Diet-Sourced Compounds in the Prevention and Treatment of Gastrointestinal Cancer |
(Eng)
|
|
W. Knackstedt R., R. Moseley V., J. Wargovich M.
|
| Vol 12, No 10 (2012) |
Chemoprevention of Breast Cancer by Dietary Compounds |
(Eng)
|
|
S. Vadodkar A., Suman S., Lakshmanaswamy R., Damodaran C.
|
| Vol 12, No 10 (2012) |
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets |
(Eng)
|
|
Pratheeshkumar P., Sreekala C., Zhang Z., Budhraja A., Ding S., Son Y., Wang X., Hitron A., Hyun-Jung K., Wang L., Lee J., Shi X.
|
| Vol 12, No 10 (2012) |
Editorial [Hot Topic: Natural Compounds as Cancer Chemopreventive and Chemotherapeutic Agents: Insights Gained from Mechanistic and Pharmacologic Studies] |
(Eng)
|
|
Ting Zhu B.
|
| Vol 12, No 1 (2012) |
New Targeted Therapies for Anaplastic Thyroid Cancer |
(Eng)
|
|
Antonelli A., Fallahi P., Ulisse S., Martina Ferrari S., Minuto M., Saraceno G., Santini F., Mazzi V., D'Armiento M., Miccoli P.
|
| Vol 12, No 1 (2012) |
Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging |
(Eng)
|
|
E. Wang R., Niu Y., Wu H., Hu Y., Cai J.
|
| Vol 12, No 1 (2012) |
Natural Products: Promising Resources for Cancer Drug Discovery |
(Eng)
|
|
Mondal S., Bandyopadhyay S., K. Ghosh M., Mukhopadhyay S., Roy S., Mandal C.
|
| Vol 12, No 1 (2012) |
Targeting Cancer Using Fragment Based Drug Discovery |
(Eng)
|
|
P. Turnbull A., M. Boyd S.
|
| Vol 12, No 1 (2012) |
Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy |
(Eng)
|
|
Arce F., Kochan G., Breckpot K., Stephenson H., Escors D.
|
| Vol 12, No 1 (2012) |
Atypical GTPases as Drug Targets |
(Eng)
|
|
Soundararajan M., Eswaran J.
|
| Vol 12, No 1 (2012) |
Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer |
(Eng)
|
|
Hardy S., G. Julien S., L. Tremblay M.
|
| Vol 12, No 1 (2012) |
Editorial [Hot Topic: Targeting G Protein and Phosphorylation Dependent Signalling Molecules for Anticancer Therapy (Guest Editor: Jeyanthy Eswaran)] |
(Eng)
|
|
Eswaran J.
|
| Vol 12, No 1 (2012) |
Preface |
(Eng)
|
|
Prudhomme M.
|
| Vol 12, No 10 (2012) |
Unifying Mechanisms of Action of the Anticancer Activities of Triterpenoids and Synthetic Analogs |
(Eng)
|
|
H. Safe S., L. Prather P., K. Brents L., Chadalapaka G., Jutooru I.
|
| Vol 12, No 10 (2012) |
Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor |
(Eng)
|
|
Moriasi C., Subramaniam D., Awasthi S., Ramalingam S., Anant S.
|
| Vol 12, No 2 (2012) |
Bisphosphonates in Lung Cancer: Can They Provide Benefits Beyond Prevention of Skeletal Morbidity? |
(Eng)
|
|
Hirsh V.
|
| Vol 12, No 2 (2012) |
Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers |
(Eng)
|
|
Saad F., Mulders P.
|
| Vol 12, No 2 (2012) |
Bisphosphonate Anticancer Activity in Multiple Myeloma |
(Eng)
|
|
Terpos E.
|
| Vol 12, No 2 (2012) |
Anticancer Activity of Bisphosphonates in Breast Cancer |
(Eng)
|
|
Gnant M.
|
| Vol 12, No 2 (2012) |
Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies |
(Eng)
|
|
Clezardin P.
|
| Vol 12, No 2 (2012) |
The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics |
(Eng)
|
|
Widler L., Jahnke W., R. Green J.
|
| Vol 12, No 2 (2012) |
Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)] |
(Eng)
|
|
Hirsh V.
|
| Vol 12, No 10 (2012) |
Acknowledgements |
(Eng)
|
|
|
| Vol 12, No 10 (2012) |
Developing Phytoestrogens for Breast Cancer Prevention |
(Eng)
|
|
M. Liu M., Huang Y., Wang J.
|
| Vol 12, No 10 (2012) |
Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability |
(Eng)
|
|
Wang H., Oo Khor T., Shu L., Su Z., Fuentes F., Lee J., Tony Kong A.
|
| Vol 12, No 10 (2012) |
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME |
(Eng)
|
|
Yang Z., Kulkarni K., Zhu W., Hu M.
|
| Vol 12, No 10 (2012) |
The Cancer Preventive Effects of Edible Mushrooms |
(Eng)
|
|
Xu T., B. Beelman R., D. Lambert J.
|
| Vol 12, No 10 (2012) |
Anti-cancer and Other Bioactivities of Korean Angelica gigas Nakai (AGN) and Its Major Pyranocoumarin Compounds |
(Eng)
|
|
Zhang J., Li L., Jiang C., Xing C., Kim S., Lu J.
|
| 801 - 900 of 1156 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 > >>
|
